ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet
- RxCUI
- 240128
- RxNorm name
- ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet
- Display name
- ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet
- Full name
- ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:24
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Estarylla | NORGESTIMATE AND ETHINYL ESTRADIOL | Bryant Ranch Prepack | e0b07fb6-8dbd-4e5d-b589-5191a1dc02ae | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 240128 |
| MONO-LINYAH | NORGESTIMATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 2ec8f18f-297c-405f-b191-a40767366bad | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 240128 |
| Norgestimate and Ethinyl Estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 35c6507c-555a-45ed-aaf6-8695831de71a | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 240128 |
| Norgestimate and Ethinyl Estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 8b247e46-203e-4f5b-b5a7-cbd57341c735 | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | 240128 |
| Tri-Estarylla | NORGESTIMATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | f7f7c073-48e0-4065-970b-8103d76b6eb0 | 2026-01-27 | Boxed warning, Warnings, Adverse reactions | 240128 |
| Norgestimate and ethinyl estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | Lupin Pharmaceuticals, Inc. | 6e8bec6f-17ba-4b37-ae6c-07657815f248 | 2025-12-09 | Boxed warning, Warnings, Adverse reactions | 240128 |
| Norgestimate and Ethinyl Estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | Lupin Pharmaceuticals, Inc. | c25cd86c-2940-475a-9628-ee75b0294e8d | 2025-12-09 | Boxed warning, Warnings, Adverse reactions | 240128 |
| Tri-Linyah | NORGESTIMATE AND ETHINYL ESTRADIOL | Northstar Rx LLC | b71a2b34-95bf-4430-83a0-1a4d1218ea3c | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 240128 |
| Tri-Sprintec | NORGESTIMATE AND ETHINYL ESTRADIOL | Preferred Pharmaceuticals Inc. | 1f8b9aad-f31f-4cda-861d-c08a977fc923 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | 240128 |
| Sprintec | NORGESTIMATE AND ETHINYL ESTRADIOL | Preferred Pharmaceuticals, Inc. | 90240210-0bca-4a55-99dc-19f2b40d8e3f | 2025-09-24 | Boxed warning, Warnings, Adverse reactions | 240128 |
| Norgestimate and Ethinyl Estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | PD-Rx Pharmaceuticals, Inc. | 00dd9b78-dd90-414b-b241-7619aa9d1ed2 | 2025-04-08 | Boxed warning, Warnings, Adverse reactions | 240128 |
| Tri-Sprintec | NORGESTIMATE AND ETHINYL ESTRADIOL | Teva Pharmaceuticals USA, Inc. | 843cbef6-cbfb-4a44-bb80-22930753e4c0 | 2025-03-12 | Boxed warning, Warnings, Adverse reactions | 240128 |
| Mono-Linyah | NORGESTIMATE AND ETHINYL ESTRADIOL | Northstar Rx LLC | 84a20017-344b-4684-a915-c85a55fcbbcb | 2025-01-20 | Boxed warning, Warnings, Adverse reactions | 240128 |
| VyLibra | NORGESTIMATE AND ETHINYL ESTRADIOL | Afaxys Pharma, LLC | 13bdc226-ecf8-4fd7-aa0e-ec19b6b74fc3 | 2025-01-04 | Boxed warning, Warnings, Adverse reactions | 240128 |
| Sprintec | NORGESTIMATE AND ETHINYL ESTRADIOL | Teva Pharmaceuticals USA, Inc. | d9252820-131a-4870-8b11-945d1bfd5659 | 2024-12-19 | Boxed warning, Warnings, Adverse reactions | 240128 |
| Mili | NORGESTIMATE AND ETHINYL ESTRADIOL | Aurobindo Pharma Limited | 76f14485-321d-4d4f-a3b0-aab195fd0dd1 | 2024-12-07 | Boxed warning, Warnings, Adverse reactions | 240128 |
| Estarylla | NORGESTIMATE AND ETHINYL ESTRADIOL | Proficient Rx LP | 7acde5ef-f457-4c47-897b-d048194c7d7e | 2024-10-01 | Boxed warning, Warnings, Adverse reactions | 240128 |
| Tri-Estarylla | NORGESTIMATE AND ETHINYL ESTRADIOL | Bryant Ranch Prepack | 6560d15f-6ce9-4f0e-9b59-043dec35ddd9 | 2024-05-21 | Boxed warning, Warnings, Adverse reactions | 240128 |
| Norgestimate and ethinyl estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | Naari Pte Limited | b936a6fb-27ed-44de-9199-8c656bcd366e | 2024-04-23 | Boxed warning, Warnings, Adverse reactions | 240128 |
| Norgestimate and ethinyl estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | Naari Pte Limited | 03de435b-b8fb-4faa-a0ec-01e48b5aaae4 | 2024-04-23 | Boxed warning, Warnings, Adverse reactions | 240128 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e0b07fb6-8dbd-4e5d-b589-5191a1dc02ae | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 104 | These highlights do not include all the information needed to use Estarylla™ safely and effectively. See full prescribing information for Estarylla™. Estarylla™ (NORGESTIMATE and ETHINYL ESTRADIOL tablets) for oral use Initial U.S. Approval: 1989 | 20240924 |
| 6560d15f-6ce9-4f0e-9b59-043dec35ddd9 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 104 | These highlights do not include all the information needed to use Tri-Estarylla safely and effectively. See full prescribing information for Tri-Estarylla. Tri-Estarylla ® (norgestimate and ethinyl estradiol, USP) tablets, for oral use Initial U.S. Approval: 1989 | 20240521 |
| 8b247e46-203e-4f5b-b5a7-cbd57341c735 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 17 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20260206 |
| 843cbef6-cbfb-4a44-bb80-22930753e4c0 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 17 | These highlights do not include all the information needed to use TRI-SPRINTEC ® safely and effectively. See full prescribing information for TRI-SPRINTEC ® . TRI-SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20250312 |
| d9252820-131a-4870-8b11-945d1bfd5659 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 13 | These highlights do not include all the information needed to use SPRINTEC safely and effectively. See full prescribing information for SPRINTEC. SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20241219 |
| 22cfceff-0429-466f-a015-33cfdc505d44 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 13 | These highlights do not include all the information needed to use TRI-MILI safely and effectively. See full prescribing information for TRI-MILI. Tri-Mili ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20240102 |
| 35c6507c-555a-45ed-aaf6-8695831de71a | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 12 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20260303 |
| 76f14485-321d-4d4f-a3b0-aab195fd0dd1 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 12 | These highlights do not include all the information needed to use MILI safely and effectively. See full prescribing information for MILI. MILI ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20241207 |
| b71a2b34-95bf-4430-83a0-1a4d1218ea3c | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 11 | These highlights do not include all the information needed to use Tri-Linyah safely and effectively. See full prescribing information for Tri-Linyah. Tri-Linyah (norgestimate/ethinyl estradiol) tablets, for oral use. Initial U.S. Approval: 1989 | 20251205 |
| c25cd86c-2940-475a-9628-ee75b0294e8d | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 10 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE AND ETHINYL ESTRADIOL tablets, for oral use Initial U.S. Approval: 1989 | 20251209 |
| f59acc3e-21d9-4fa3-ad52-d77225739e1a | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 10 | These highlights do not include all the information needed to use Tri-VyLibra safely and effectively. See full prescribing information for Tri-VyLibra. Tri-VyLibra ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20240202 |
| 84a20017-344b-4684-a915-c85a55fcbbcb | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 9 | These highlights do not include all the information needed to use Mono-Linyah safely and effectively. See full prescribing information for Mono-Linyah. Mono-Linyah (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval:1989 | 20250120 |
| 1ba8a8ab-eb09-0807-47d4-6b4055d10d91 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 9 | These highlights do not include all the information needed to use Tri-Estarylla safely and effectively. See full prescribing information for Tri-Estarylla. Tri-Estarylla ® (norgestimate and ethinyl estradiol, USP) tablets, for oral use Initial U.S. Approval: 1989 | 20230801 |
| 59bce25b-ee2c-4f06-afff-e5141d063602 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 9 | These highlights do not include all the information needed to use FEMYNOR safely and effectively. See full prescribing information for FEMYNOR. FEMYNOR™ (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20160530 |
| 6e8bec6f-17ba-4b37-ae6c-07657815f248 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 8 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS USP safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS USP. NORGESTIMATE and ETHINYL ESTRADIOL tablets USP, for oral use Initial U.S. Approval: 1989 | 20251209 |
| 1f8b9aad-f31f-4cda-861d-c08a977fc923 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 8 | These highlights do not include all the information needed to use TRI-SPRINTEC ® safely and effectively. See full prescribing information for TRI-SPRINTEC ® . TRI-SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20251001 |
| 90240210-0bca-4a55-99dc-19f2b40d8e3f | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 8 | These highlights do not include all the information needed to use SPRINTEC safely and effectively. See full prescribing information for SPRINTEC. SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20250924 |
| 00dd9b78-dd90-414b-b241-7619aa9d1ed2 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 8 | These highlights do not include all the information needed to use SPRINTEC safely and effectively. See full prescribing information for SPRINTEC. SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20250408 |
| 13bdc226-ecf8-4fd7-aa0e-ec19b6b74fc3 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 8 | These highlights do not include all the information needed to use VyLibra safely and effectively. See full prescribing information for VyLibra. VyLibra ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20250104 |
| 6ae97238-28cf-4bc9-a4ba-1e2bf4e3c600 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 8 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20230328 |
| 7a4d2d7b-b97e-3e18-3d97-1e2579c8f3f8 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 7 | These highlights do not include all the information needed to use Estarylla safely and effectively. See full prescribing information for Estarylla. Estarylla ® (NORGESTIMATE and ETHINYL ESTRADIOL tablets) for oral use Initial U.S. Approval: 1989 | 20230201 |
| 2ec8f18f-297c-405f-b191-a40767366bad | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 6 | These highlights do not include all the information needed to use Mono-Linyah safely and effectively. See full prescribing information for Mono-Linyah. Mono-Linyah (norgestimate/ethinyl estradiol tablets) for oral use. Initial U.S. Approval:1989 | 20240507 |
| 46bbdf70-2b80-4359-a19b-d94ff99eac98 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 6 | These highlights do not include all the information needed to use TRI FEMYNOR safely and effectively. See full prescribing information for TRI FEMYNOR. TRI FEMYNOR™ (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20160830 |
| 03de435b-b8fb-4faa-a0ec-01e48b5aaae4 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 5 | NORGESTIMATE and ETHINYL ESTRADIOL tablets USP These highlights do not include all the information needed to use NORGESTIMATE and ETHINYL ESTRADIOL TABLETS USP safely and effectively. See full prescribing information for NORGESTIMATE and ETHINYL ESTRADIOL TABLETS USP. NORGESTIMATE and ETHINYL ESTRADIOL tablets, for oral use Initial U.S. Approval: 1989 | 20240423 |
| b936a6fb-27ed-44de-9199-8c656bcd366e | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 5 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS USP safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS USP. NORGESTIMATE and ETHINYL ESTRADIOL tablets USP, for oral use Initial U.S. Approval: 1989 | 20240423 |
| 3e8149e1-ada2-4f3d-996b-466759cbb344 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 5 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20230607 |
| 4e1927bd-378d-45dc-8b18-3dd57ccd2cb6 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 5 | These highlights do not include all the information needed to use SPRINTEC safely and effectively. See full prescribing information for SPRINTEC. SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20220401 |
| beabee48-1912-47bf-a9b5-d5c426c4fcc2 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 5 | Norgestimate and Ethinyl Estradiol Tablets USP, 0.25 mg/0.035 mg | 20120413 |
| 4a159dcd-8af4-4e59-8f46-7b0fe5c22807 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 4 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20220401 |
| f7f7c073-48e0-4065-970b-8103d76b6eb0 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 3 | These highlights do not include all the information needed to use Tri-Estarylla safely and effectively. See full prescribing information for Tri-Estarylla. Tri-Estarylla ® (norgestimate and ethinyl estradiol, USP) tablets, for oral use Initial U.S. Approval: 1989 | 20260127 |
| a3c0c983-7ec7-244a-e053-2995a90adbe4 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 3 | Norgestimate and Ethinyl Estradiol Tablets, USP These highlights do not include all the information needed to use Norgestimate and Ethinyl Estradiol Tablets, USP safely and effectively. See full prescribing information for Norgestimate and Ethinyl Estradiol Tablets, USP. Initial U.S. Approval: 1989 | 20240110 |
| a3cfd79e-a344-1dfc-e053-2995a90a1ab7 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 3 | Norgestimate and Ethinyl Estradiol Tablets, USP These highlights do not include all the information needed to use Norgestimate and Ethinyl Estradiol Tablets, USP safely and effectively. See full prescribing information for Norgestimate and Ethinyl Estradiol Tablets, USP. Initial U.S. Approval: 1989 | 20240110 |
| 02e5c9a1-6002-499e-abe2-8473a5854178 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 3 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20231004 |
| 8a4aa52f-fe7b-4814-9488-009fddfbfbb1 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 3 | These highlights do not include all the information needed to use Tri-VyLibra safely and effectively. See full prescribing information for Tri-VyLibra. Tri-VyLibra ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20230607 |
| e5b71df3-d99e-4e2d-a0cf-4c2790a6907d | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 3 | These highlights do not include all the information needed to use VyLibra safely and effectively. See full prescribing information for VyLibra. VyLibra ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20230607 |
| c1fc22e5-e02d-4dda-a9ac-c592e922c467 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 3 | Tri-Sprintec ® (norgestimate and ethinyl estradiol tablets USP) | 20200101 |
| 0d754d53-2a8b-40c8-9008-64390cd72dd0 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 2 | These highlights do not include all the information needed to use TRI FEMYNOR safely and effectively. See full prescribing information for TRI FEMYNOR. TRI FEMYNOR™ (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20200118 |
| 643b9e90-2bfc-411d-89cc-344add0e4205 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 2 | These highlights do not include all the information needed to use MonoNessa or TriNessa safely and effectively. See full prescribing information for MonoNessa and TriNessa. MonoNessa ® and TriNessa ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20190412 |
| 8a2c68c4-9cf9-48c5-9b97-e38e7c5e0a03 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 2 | These highlights do not include all the information needed to use MonoNessa or TriNessa safely and effectively. See full prescribing information for MonoNessa and TriNessa. MonoNessa ® and TriNessa ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20190109 |
| 162540df-d6a5-4c0c-b478-3e7720e7beb6 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet [PSN] · ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet [SCD] · ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet [SY] | 3 | 2 | These highlights do not include all the information needed to use PREVIFEM ® or TRI-PREVIFEM ® safely and effectively. See full prescribing information for PREVIFEM ® and TRI-PREVIFEM ® . PREVIFEM ® and TRI-PREVIFEM ® (norgestimate/ethinyl estradiol tablets), for oral use Initial U.S. Approval: 1989 | 20161202 |